P0DPI1 (BXA1_CLOBH) Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Botulinum neurotoxin type A UniProtKBProtein AtlasInterProInteractive Modelling
1296 aa; Sequence (Fasta) ;
1 identical sequence: Clostridium botulinum: Q7B8V4
It is possible new templates exist for this target since these models were created.
Available Structures
68 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| 2.7 angstrom crystal structure of BoNT/Ai in complex with NTNHA |
Heteromer Q45914; | 99.69 | 1×ZN; 1×CA; 20×SO4; 4×MES; | |||
| 3.9 angstrom crystal structure of BoNT/Ai in complex with NTNHA |
Heteromer Q45914; | 99.69 | 1×ZN; 1×CA; | |||
| Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody CR1 |
Heteromer | 99.92 | 1×ZN; 1×CA; | |||
| Crystal structure of botulinum neurotoxin type A complexed with monoclonal antibody AR2 |
Heteromer | 99.92 | 1×ZN; 1×CA; | |||
| Crystal Structure of a Catalytically Active, Non-toxic Endopeptidase Derivative of Clostridium botu… |
Heteromer | 99.54 | 2×SO4; 1×ZN; 2×CL; 5×GOL; | |||
| Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7 |
Heteromer | 99.65 | ||||
| Crystal structure of BoNT/A-LCHn domain in complex with VHH ciA-D12, ciA-B5, and ciA-H7 |
Heteromer | 99.65 | ||||
| LC/A-JPU-B9-JPU-A11-JPU-G11 |
Heteromer | 100.0 | 2×ZN; | |||
| Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12 |
Heteromer | 99.77 | 1×ZN; | |||
| Crystal structure of BoNT/A receptor binding domain in complex with VHH C2 |
Heteromer | 99.76 | ||||
| Receptor binding domain of Botulinum neurotoxin A in complex with human glycosylated SV2C |
Heteromer Q496J9; | 99.76 | 1×NAG; 1×ACT; 2×PO4; 1×NAG; | |||
| Receptor binding domain of Botulinum neurotoxin A in complex with rat SV2C |
Heteromer Q9Z2I6; | 99.76 | ||||
| Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a snap-25 peptide |
Heteromer P60880; | 100 | 1×ZN; 1×SO4; | |||
| Crystal structure of the catalytic domain of Botulinum neurotoxin serotype a with a substrate analo… |
Heteromer P60880; | 100 | 1×ZN; 2×SO4; | |||
| CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL… |
Heteromer Q496J9; | 100.0 | 6×CL; 2×NA; | |||
| Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12 |
Heteromer | 100.0 | 2×EDO; 1×ZN; | |||
| Crystal structure of NEUROTOXIN BONT/A complexed with Synaptosomal-associated protein 25 |
Heteromer P60880; | 99.52 | 1×ZN; 1×CL; | |||
| Crystal structure of the LC/A1-DARPin18 complex |
Heteromer | 100 | 1×ZN; | |||
| Crystal Structure of a Llama Antibody complexed with the C. Botulinum Neurotoxin Serotype A Catalyt… |
Heteromer | 99.58 | 2×ZN; | |||
| Crystal structure of an engineered botulinum neurotoxin type A- SNARE23 derivative, LC0-A-SNAP25-Hn… | homo-2-mer | 99.53 | 5×SO4; | |||
| CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A | monomer | 99.92 | 1×ZN; | |||
| 4.3 angstrom crystal structure of an inactive BoNT/A (E224Q/R363A/Y366F) | monomer | 99.69 | 1×ZN; | |||
| Crystal structure of an engineered botulinum neurotoxin type A- SNARE23 derivative, LC-A-SNAP23-Hn-A | monomer | 100 | 1×ZN; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134S/C165S double mutant | monomer | 99.53 | 1×ZN; 2×GOL; 2×IMD; 1×EDO; | |||
| Structure of the C. botulinum neurotoxin serotype A with an inhibitory peptide bound | monomer | 99.52 | 1×ZN; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134 mutant with MTSEA mod… | monomer | 99.53 | 1×ZN; 4×DMS; 1×LMR; 1×GOL; 9×EDO; 2×NA; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134 mutant with MTSEA mod… | monomer | 99.53 | 1×ZN; 2×IMD; 1×LMR; 3×DMS; 2×SO4; 2×MPD; 3×LI; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A wild-type | monomer | 100 | 1×ZN; 3×EDO; 1×SO4; 1×IMD; 1×CO3; 1×GOL; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134S mutant with covalent… | monomer | 99.77 | 1×ZN; 1×SO4; 3×GOL; 1×PEG; 2×PGO; 3×EDO; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin BoNT/A C134S mutant with covalent… | monomer | 99.77 | 1×ZN; 1×PGO; 1×SO4; 3×GOL; | |||
| Structure of the C. botulinum neurotoxin serotype A apo-enzyme | monomer | 99.76 | ||||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with inhibitory peptid… | monomer | 100 | 1×ZN; 3×SO4; | |||
| CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B | monomer | 99.53 | 1×BGC; 1×MG; | |||
| Crystal structure of the protease domain of Botulinum Neurotoxin Serotype A with a peptide inhibito… | monomer | 100 | 1×ZN; 3×SO4; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with an acetate ion bo… | monomer | 100 | 1×ZN; 2×SO4; 1×ACT; | |||
| Crystal Structure of the Botulinum Neurotoxin Serotype A binding domain | monomer | 99.53 | ||||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with a Novel Cyclic Pe… | monomer | 99.76 | 1×ZN; 3×SO4; | |||
| Structure of the C. botulinum neurotoxin serotype A with Zn2+ cofactor bound | monomer | 99.76 | 1×ZN; | |||
| Crystal structure of the protease domain of Botulinum Neurotoxin Serotype A with a peptide inhibito… | monomer | 100 | 1×ZN; 3×SO4; 1×NA; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with inhibitory peptid… | monomer | 100 | 1×ZN; 3×SO4; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with inhibitory peptid… | monomer | 100 | 1×ZN; 3×SO4; | |||
| Crystal structure of the protease domain of Botulinum Neurotoxin Serotype A with a peptide inhibito… | monomer | 100 | 1×ZN; 3×SO4; 1×NA; 1×EDO; | |||
| Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with inhibitory peptid… | monomer | 100 | 1×ZN; 2×SO4; 1×NA; | |||
| Crystal structure of the protease domain of Botulinum Neurotoxin Serotype A with a peptide inhibito… | monomer | 100 | 1×ZN; 3×SO4; 1×NA; | |||
| Crystal structure of the receptor-binding domain of botulinum neurotoxin A1 (crystal form 1) | monomer | 100 | 1×NA; | |||
| The Crystal structure of receptor binding domain of botulinum neurotoxin serotype A | monomer | 100.0 | ||||
| Binding domain of BoNT/A complexed with ganglioside | monomer | 100 | 1×GAL; 1×NGA; | |||
| Structure of the C. botulinum neurotoxin serotype A with Hg bound | monomer | 99.53 | 1×HG; 1×ACT; | |||
| Crystal Structure of HCRA-W1266A | monomer | 99.76 | 2×GOL; | |||
| Structure of the C. botulinum neurotoxin serotype A with Cu bound | monomer | 99.53 | 2×CU; 1×ACT; | |||
| Binding domain of BoNT/A complexed with ganglioside variant | monomer | 100.0 | ||||
| Clostridium botulinum Serotype A Light Chain inhibited by 4-chlorocinnamic hydroxamate | monomer | 99.75 | 1×ZN; 1×PO4; 1×GB5; | |||
| Botulinum Neurotoxin A Light Chain WT Crystal Form A | monomer | 100 | 1×ZN; | |||
| neurotoxin BoNT/A E224Q Y366F mutant | monomer | 99.52 | 1×ZN; | |||
| Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain | monomer | 99.74 | 1×ZN; 1×90J; | |||
| Clostridium botulinum Neurotoxin Serotype A Light Chain, Residues 1-424 | monomer | 99.74 | 1×ZN; | |||
| Clostridium botulinum Neurotoxin Serotype A Light Chain Inhibited by L-arginine hydroxamate | monomer | 99.74 | 1×ZN; 1×AHL; | |||
| Clostridium botulinum Neurotoxin Serotype A Light Chain Inhibited by a Chiral Hydroxamic Acid | monomer | 99.74 | 1×ZN; | |||
| Crystal structure of BoNT/A LC with JTH-NB-7239 peptide | monomer | 100.0 | 1×ZN; 1×NI; | |||
| Clostridium Botulinum Serotype A Light Chain Inhibited By Adamantane Hydroxamate | monomer | 99.74 | 1×ZN; 1×AXM; | |||
| A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformat… | monomer | 100.0 | 1×ZN; 1×NI; | |||
| Botulinum Neurotoxin A Light Chain WT Crystal Form B | monomer | 100 | 1×ZN; | |||
| Botulinum Neurotoxin A Light Chain WT Crystal Form C | monomer | 100 | 1×ZN; | |||
| Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain | monomer | 99.74 | 1×ZN; 1×90M; | |||
| Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain | monomer | 99.73 | 1×ZN; 1×90G; | |||
| Botulism Neurooxin Light Chain A app form | monomer | 100.0 | 1×ZN; | |||
| A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformat… | monomer | 100.0 | 1×ZN; 1×NI; | |||
| Crystal structure of the receptor-binding domain of botulinum neurotoxin A1 (crystal form 2) | monomer | 100.0 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3v0b.1.A | monomer | 0.80 | 1×ZN; 1×CA; | 99.69 | ||
| 2nz9.1.A | monomer | 0.78 | 1×ZN; 1×CA; | 99.92 | ||